MedTrace Logo

Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München

NCT00855634 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 355

Last updated 2012-09-06

No results posted yet for this study

Summary

PaMeViTUM is a mono-centric prospective randomized controlled trial that compares different operating procedures in patients with pancreatic cancer and minimal metastatic disease or venous infiltration.

Conditions

Interventions

PROCEDURE

Resection of metastases

resection of the primary tumor, followed by resection of the liver metastasis/metastases

PROCEDURE

Resection of infiltrated veins

resection of the primary tumor with resection of the portal vein (and/or superior mesenteric vein/splenic

Sponsors & Collaborators

  • Technical University of Munich

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Completion
2012-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00855634 on ClinicalTrials.gov